Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'

Cephalalgia. 2024 Oct;44(10):3331024241293104. doi: 10.1177/03331024241293104.
No abstract available

Publication types

  • Letter